Comments & Letters

State Medicaid Plan Non-Recognition of Proprietary Laboratory Analysis (PLA) Codes

POCTA leads letter to the Centers for Medicare and Medicaid Services (CMS) encourage the agency to instruct State Medicaid programs to recognize and process claims submitted with Proprietary Laboratory Analysis (“PLA”) codes established by the American Medical Association’s Current Procedural Terminology (“CPT”) Editorial Panel.

POCTA Urges HEC Committee to Include Diagnostic Testing Preparedness Plan in Pandemic and All-Hazards Preparedness Act (PAHPA)

POCTA writes letter of support to House Energy and Commerce Committee leadership for the diagnostic testing plan requirements included as part of the Pandemic All Hazards Preparedness Act (HR 4421).

37 Consumer and Patient Advocacy Groups Urge Congress to Enact SALSA

Thirty-seven consumer and patient advocacy groups voiced support for SALSA. These groups sent a letter to congressional leadership urging Congress to take action to enact SALSA this year and prevent a fourth round of Medicare payment cuts in January 2024. We are grateful to the National Consumers League and RetireSafe for their leadership on this issue.

POCTA and QuidelOrtho Comment to CMMS on CY 2023 Clinical Laboratory Fee Schedule (CLFS)

POCTA, joined by QuidelOrtho, submitted comments to Centers for Medicare and Medicaid Services on the CY 2023 Clinical Laboratory Fee Schedule (CLFS) Preliminary Payment Determinations to inform the final CLFS rate determination for CPT code 87428. (CPT code 87428 describes instrumented antigen testing by immunoassay that reports separate (qualitative) results for COVID-19, influenza A, and influenza B.)

Patient Advocates Send Letter to Congress Urging the Saving Access to Laboratory Services Act be Enacted

Patient advocates with a strong interest in diagnostics send a letter to Speaker Pelosi, Leader Schumer, and Minority Leaders McCarthy and McConnell urging that the Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) be enacted this year.

POCTA Submits Letter to Congress Explaining Why the Saving Access to Laboratory Services Act is Necessary

POCTA submits a letter to Speaker Pelosi, Leader Schumer, and Minority Leaders McCarthy and McConnell explaining that the enactment of the Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) is urgently needed this year, to allow laboratories to focus on providing timely, high quality clinical laboratory services for patients, continuing to innovate, and building the infrastructure necessary to protect the public health.

POCTA Responds to CMMS on Medicare and Medicaid Programs; CY 2023 Payment Policies under the Physician Fee Schedule Phase-in of PAMA Payment Reductions

POCTA responds to the Centers for Medicare and Medicaid Services on the Proposed Rule entitled, “Medicare and Medicaid Programs; CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Medicare and Medicaid Provider Enrollment Policies, Including for Skilled Nursing Facilities; Conditions of Payment for Suppliers of Durable Medicaid Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); and Implementing Requirements for Manufacturers of Certain Single-Dose Container or Single-Use Package Drugs To Provide Refunds With Respect to Discarded Amounts”.

Go to Top